These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 5077118)

  • 41. [Changes in the blood coagulation in patients with pulmonary tuberculosis during treatment with preparations of the first order].
    Ivaniuta OM; Fomicheva NI; Chaban VM
    Vrach Delo; 1969 Aug; 8():38-9. PubMed ID: 5382482
    [No Abstract]   [Full Text] [Related]  

  • 42. The John Barnwell Lecture. Changing concepts in the chemotherapy of pulmonary tuberculosis.
    Fox W
    Am Rev Respir Dis; 1968 May; 97(5):767-90. PubMed ID: 4171718
    [No Abstract]   [Full Text] [Related]  

  • 43. Course of cases of pulmonary tubercurosis with bacilli resistant to streptmycin, para-aminosalicylic acid and isoniazid and with multiple drug-resistance.
    Oka S
    Sci Rep Res Inst Tohoku Univ Med; 1969 Dec; 16(3):106-9. PubMed ID: 4988512
    [No Abstract]   [Full Text] [Related]  

  • 44. [Comparison between SM daily and twice weekly treatment in the regimen of SM, INH and PAS--particularly considering the degree of drug resistance (Report 2) (author's transl)].
    Baba H; Azuma Y
    Kekkaku; 1977 Dec; 52(12):619-26. PubMed ID: 604603
    [No Abstract]   [Full Text] [Related]  

  • 45. Efficacy of thiacetazone plus isoniazid in Hong Kong: a Hong Kong tuberculosis treatment service-British Medical Research Council investigation.
    Horsfall PA
    Tubercle; 1968 Mar; 49():Suppl:30-2. PubMed ID: 4173325
    [No Abstract]   [Full Text] [Related]  

  • 46. [Evaluation of alternative regimen of SM-INH-PAS and KM-TH-CS at three months interval in initial treatment of far advanced pulmonary tuberculosis. A report of the 12th series controlled trial of chemotherapy].
    Kekkaku; 1972 Jun; 47(6):151-8. PubMed ID: 5081204
    [No Abstract]   [Full Text] [Related]  

  • 47. [Evaluation of high dose INH twice weekly regimen in the original treatment for moderately advanced pulmonary tuberculosis. A report of the 12th series B study of the controlled trials].
    Kekkaku; 1972 Jun; 47(6):159-66. PubMed ID: 4562924
    [No Abstract]   [Full Text] [Related]  

  • 48. [Treatment of pulmonary tuberculosis with intermittent dosage of streptomycin and isoniazid].
    Kisielewicz J; Fafrowicz B; Jablonowski Z; Kociecka I; Turczynowski R
    Gruzlica; 1970; 38(7):719-22. PubMed ID: 5453681
    [No Abstract]   [Full Text] [Related]  

  • 49. [Clinical experience in the single administration of daily doses of chemical preparations].
    Pozdniakova EI; Matiashvili NA
    Probl Tuberk; 1970; 48(4):89-90. PubMed ID: 5471139
    [No Abstract]   [Full Text] [Related]  

  • 50. [Results of short-term tuberculostatic treatment at the end of the therapeutic regimen].
    Tănase C; Baraneţchi C
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1983; 32(1):43-7. PubMed ID: 6312534
    [No Abstract]   [Full Text] [Related]  

  • 51. A controlled comparison of two fully supervised once-weekly regimens in the treatment of newly diagnosed pulmonary tuberculosis.
    Tubercle; 1973 Mar; 54(1):23-45. PubMed ID: 4204397
    [No Abstract]   [Full Text] [Related]  

  • 52. Hong Kong tuberculosis treatment services/British Medical Research Council Study of 6- and 9-month regimens of daily and intermittent streptomycin, isoniazid and pyrazinamide for pulmonary tuberculosis.
    Allan WG
    Bull Int Union Tuberc; 1976; 51(1):91-3. PubMed ID: 1030317
    [No Abstract]   [Full Text] [Related]  

  • 53. [Evaluation of initial combined chemotherapy with SM, INH and EB for pulmonary tuberculosis. 2. Comparison of SM, EB and INH regimen with that of SM, PAS and INH for experimental tuberculosis of mice].
    Makiyama H
    Kekkaku; 1971 Aug; 46(8):303-8. PubMed ID: 5570128
    [No Abstract]   [Full Text] [Related]  

  • 54. Comparison between high daily dosage of isoniazid in divided doses and low daily dosage in a single dose in triple-drug regimens.
    Tubercle; 1968 Jun; 49(2):170-9. PubMed ID: 5664315
    [No Abstract]   [Full Text] [Related]  

  • 55. Comparison of the clinical usefulness of ethionamide and prothionamide in initial treatment of tuberculosis: tenth series of controlled trials.
    Tubercle; 1968 Sep; 49(3):281-90. PubMed ID: 4884773
    [No Abstract]   [Full Text] [Related]  

  • 56. [New combinations of drugs for the treatment of drug-resistant tuberculosis].
    Schmelev NA
    Bull Int Union Tuberc; 1968 Dec; 41():192-3. PubMed ID: 5710248
    [No Abstract]   [Full Text] [Related]  

  • 57. [Treatment of siderosilicotuberculosis patients with intravenous administration of antibacterial preparations].
    Malov VV; Buidenok TV
    Probl Tuberk; 1972; 50(6):66-7. PubMed ID: 5051131
    [No Abstract]   [Full Text] [Related]  

  • 58. [Blood bacteriostatic activity in patients depending on the type of inactivation of isonicotinic acid hydrazide in the body].
    Gil'madinova RSh; Bakanova DIa
    Antibiotiki; 1971 Jan; 16(1):87-90. PubMed ID: 4994900
    [No Abstract]   [Full Text] [Related]  

  • 59. Causes of failure of domiciliary chemotherapy in pulmonary tuberculosis.
    Pamra SP; Prasad G; Mathur GP
    Tubercle; 1973 Sep; 54(3):185-94. PubMed ID: 4129693
    [No Abstract]   [Full Text] [Related]  

  • 60. [Rapid intravenous administration of isoniazid in treating newly detected destructive pulmonary tuberculosis].
    Shchutskaia EI; Khlebnikova LA; Derbikova TI; Ivanova GT
    Probl Tuberk; 1980 Feb; (2):41-4. PubMed ID: 7375460
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.